title: Oral contraceptive health benefits: perception versus reality.
abstract: Many women remain unaware of classic oral contraceptive (OC) noncontraceptive health benefits even as new health advantages emerge from experience and research. An extensive body of evidence has established that OC protect women against dysmenorrhea and menorrhagia, menstrual cycle irregularities, iron deficiency anemia, ectopic pregnancy, pelvic inflammatory disease, ovarian cysts, benign breast disease, endometrial cancer, and ovarian cancer. In addition, the FDA has stated for the first time that an OC-triphasic norgestimate/35 micrograms ethinyl estradiol--is an effective treatment for moderate acne vulgaris. OC use also appears to prevent osteopenia in hypoestrogenic women. In addition to these noncontraceptive health benefits, OC have proven valuable in the management of a variety of gynecologic disorders, including dysfunctional uterine bleeding, persistent anovulation, premature ovarian failure, functional ovarian cysts, pelvic pain (including secondary dysmenorrhea), mittelschmerz, endometriosis, and the control of bleeding in women with blood dyscrasias. Educating healthcare providers and women about these important noncontraceptive health benefits will result in increased compliance, greater continuation, and fewer unintended pregnancies.
authors.affiliation: Department of Obstetrics and Gynecology, University of Florida Health Science Center, Jacksonville 32209, USA.
authors.forename: A M
authors.initials: AM
authors.lastname: Kaunitz
mesh_terms: D000152:Acne Vulgaris / Q000517:prevention & control; D000740:Anemia / Q000517:prevention & control; D003278:Contraceptives, Oral, Hormonal / Q000627:therapeutic use*; D003280:Contraceptives, Oral, Synthetic / Q000627:therapeutic use*; D004412:Dysmenorrhea / Q000517:prevention & control; D016889:Endometrial Neoplasms / Q000517:prevention & control; D004997:Ethinyl Estradiol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010024:Osteoporosis / Q000517:prevention & control; D010051:Ovarian Neoplasms / Q000517:prevention & control; D000292:Pelvic Inflammatory Disease / Q000517:prevention & control; D011247:Pregnancy; D011271:Pregnancy, Ectopic / Q000517:prevention & control
chemical_list: D003278:Contraceptives, Oral, Hormonal; D003280:Contraceptives, Oral, Synthetic; D004997:Ethinyl Estradiol